Aeglea Biotherapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Quarterly reported holdings in Aeglea Biotherapeutics by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $9.1M | 392k | 23.28 |
2024-09-30 | $1.7M | 58k | 29.41 |
2024-06-30 | $1.0M | 45k | 23.51 |
2024-03-31 | $99k | 2.6k | 37.93 |
2023-12-31 | $80k | 3.7k | 21.52 |